![John Brock-Utne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Brock-Utne
Corporate Officer/Principal chez Stanford University Hospital
Profil
John Brock-Utne is currently working as a Principal at Stanford University Hospital.
Prior to this, he worked as a Director at Spectros Corp.
Postes actifs de John Brock-Utne
Sociétés | Poste | Début |
---|---|---|
Stanford University Hospital
![]() Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Corporate Officer/Principal | 14/05/2010 |
Anciens postes connus de John Brock-Utne
Sociétés | Poste | Fin |
---|---|---|
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Spectros Corp.
![]() Spectros Corp. Medical SpecialtiesHealth Technology Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA. | Health Technology |
Stanford University Hospital
![]() Stanford University Hospital Hospital/Nursing ManagementHealth Services Stanford University Hospital operates as a hospital. The private company is based in Palo Alto, CA. | Health Services |